TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
PMN

ProMIS Neurosciences Inc.

Healthcare · Biotechnology

3.30$ -5.5% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns ProMIS Neurosciences Inc. (PMN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.5% of the shares are freely tradable; institutional investors hold 74.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 74.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 11.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 48.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 9Mio.

Largest Shareholders

Institutions

Institutions PMN
Name Stake (%) Shares Change (%) Date
Jupiter Topco LLC 14.42 1,292,757 +0.0 06/30/2026
Deep Track Capital, LP 9.32 835,655 +0.0 06/30/2026
Wellington Management Company LLP 7.77 696,378 +0.0 06/30/2026
Ally Bridge Group (NY) LLC 6.92 620,319 +49.8 06/30/2026
Trails Edge Capital Partners, LP 6.21 557,103 +0.0 06/30/2026
Woodline Partners LP 4.93 441,911 +11.8 06/30/2026
Yu Fan 3.68 329,760 +0.0 06/30/2026
Sphera Funds Management Ltd. 3.63 325,591 +0.0 06/30/2026
Squadron Capital Management LLC 3.62 324,977 +0.0 06/30/2026
Ikarian Capital, LLC 2.29 205,000 +272.7 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings PMN
Person Role Shares Value As of Type
Williams Eugene Director 40,213 132,703 $ Nov 4, 2026 direct
Cashman Neil Chief Scientific Officer 14,532 47,956 $ Nov 2, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Nov 4, 2026 Williams Eugene Director Buy 26,500 3.43 90,895
Nov 2, 2026 Cashman Neil Chief Scientific Officer Buy 10,000 3.86 38,600
Oct 30, 2026 Williams Eugene Director Buy 1,316 3.99 5,251
Apr 22, 2026 Patrick D Kirwin Director Buy 4,000 11.33 45,320

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?